课题基金 / 基金详情

Towards Universal Chemosensory Testing

Towards Universal Chemosensory Testing
迈向通用化学感应测试
批准号:
10683613
负责人:
MARK W ALBERS
金额:
$4.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-04-01 至 2024-03-31

项目摘要

项目成果

MARK W ALBERS的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 新冠肺炎大流行使嗅觉和味觉功能障碍引起了主流关注。尽管它在 信号疾病,以及安全性、依恋和生活质量,化学感觉障碍的诊断是 远离大多数患者可及的地方,或大多数医疗服务提供者经常雇用的人。与 为了实现2022-2027年NIDCD战略规划草案的目标,我们提议召开一次会议,将 科学家、临床医生、公共卫生官员、患者和所有其他有关各方,以确定机会和 在全国范围内实施常规化学传感测试的挑战。组织和执行 会议是由四位具有不同科学和临床背景的领导人共同努力的结果 化学感官检测的应用代表在这些领域具有独特专业知识的机构。 这次会议的与会者将(I)分享最先进的化学传感测试方法;(Ii)确定 化学感官筛查对个人和人群的益处和实用性; 将这一信息传达给医学协会、卫生保健专业人员、学术机构、 政府机构、保险公司、工业界和公众;以及(Iv)产生一个同行-- 关于普遍化学传感测试的经审查的共识白皮书详细说明了 会议提出的建议,包括一项以指导方针为蓝本的战略 其他成功的宣传活动。这次面对面的会议将包括虚拟组件和儿童保育 援助,从而使不同群体能够更广泛地参与。我们还将制作视频, 在线提供演示文稿,并为非专业公众生成简明易懂的材料,西班牙语和 英语,作为外展内容。综合起来,这些活动将推动化学感官检测在 多个上下文,以加快化学感觉障碍和相关健康问题的诊断,促进 为受影响的个人提供治疗和支持性干预,并改善人类健康和生活质量。
英文摘要
PROJECT SUMMARY The COVID-19 pandemic has brought smell and taste dysfunction to mainstream attention. Despite its role in signaling disease, as well as safety, attachment, and quality of life, the diagnosis of chemosensory disorders is far from accessible for most patients or routinely employed by most health care providers. Aligned with the goals of the 2022-2027 draft of the NIDCD Strategic Plan, we propose a conference to bring together scientists, clinicians, public health officials, patients and all other interested parties to identify opportunities and challenges for implementing routine chemosensory testing nationwide. The organization and execution of the conference result from a collaborative effort of four leaders with diverse backgrounds in the science and clinical application of chemosensory testing who represent institutions with distinct expertise in these areas. Participants in this conference will (i) share state-of-the-art methods in chemosensory testing; (ii) identify benefits and practicalities of chemosensory screening both for individuals and at the population level; (iii) communicate this information to medical associations, health care professionals, academic institutions, governmental agencies, insurance companies, industry, and the general public; and (iv) produce a peer- reviewed, consensus white paper for universal chemosensory testing detailing the rationale and recommendations that emerge from the conference, including a strategy to produce guidelines modeled on other successful campaigns. This in-person conference will include virtual components and childcare assistance, thus enabling the wider participation of diverse groups. We will also make videos of the presentations available online and generate Plain Language materials for the lay public, with both Spanish and English, as outreach content. Together, these activities will advance the use of chemosensory testing in multiple contexts, to speed diagnosis of chemosensory disorders and associated health problems, facilitate therapeutic and supportive interventions for affected individuals, and improve human health and quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD
  • 批准号:
    10502780
  • 项目类别:
  • 资助金额:
    $248.18万
  • 财政年份:
    2022
  • 负责人:
    MARK W ALBERS
  • 依托单位:
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
  • 批准号:
    10321005
  • 项目类别:
  • 资助金额:
    $43.66万
  • 财政年份:
    2020
  • 负责人:
    MARK W ALBERS
  • 依托单位:
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
  • 批准号:
    10439178
  • 项目类别:
  • 资助金额:
    $87.73万
  • 财政年份:
    2020
  • 负责人:
    MARK W ALBERS
  • 依托单位:
Harnessing Diverse BioInformatic Approaches to Repurpose Drugs for Alzheimers Disease
  • 批准号:
    9974450
  • 项目类别:
  • 资助金额:
    $75.93万
  • 财政年份:
    2018
  • 负责人:
    MARK W ALBERS
  • 依托单位:
海外基金